]>Advances in Molecular Characterization and Targeted Therapy in Dermatofibrosarcoma Protuberans : Figure 3
959132.fig.003a
(a)
959132.fig.003b
(b)
959132.fig.003c
(c)
Figure 3: Images of advanced dermatofibrosarcoma protuberans of the supraclavicular region before and after therapy with imatinib, and after resection of residual disease. The patient is now 3 years free of disease.